Group 1 - The economic outlook for Mitsui & Co. has become more uncertain since March, particularly due to the "Liberation Day" US tariffs on imports [1] - The author has a long-term investment strategy, focusing on maximizing total return by purchasing assets when their price is low relative to intrinsic value [1] - The author has been managing their own portfolio since 1998, achieving returns that match the S&P 500 with lower volatility and higher income [1] Group 2 - The article does not provide any specific financial data or performance metrics related to Mitsui & Co. or the broader industry [3]

Core Viewpoint - Vici Properties has demonstrated superior growth compared to its peers, with a 7% compound annual growth rate in dividend payments since its inception, significantly outpacing the 2% average of other triple net REITs [1] Group 1: Growth Strategy - The company's focus on strategic partnerships is a crucial driver of its above-average growth, enabling portfolio expansion and increased cash flow [2] - Vici Properties invests in experiential real estate sectors such as gaming, hospitality, and entertainment, positioning itself as a partner rather than just a landlord [3] - Long-standing partnerships with major operators, including Caesars Entertainment and MGM Resorts, enhance revenue generation through steady rental income [4][5] Group 2: Capital Support and Investment Opportunities - Vici Properties provides additional capital to tenants for expansion through various means, including sale-leaseback transactions and loans, creating mutually beneficial partnerships [6] - The company has supported Great Wolf Lodge with over $720 million in capital since 2021 and provided $700 million for renovations at The Venetian Las Vegas, leading to increased rental income [7] Group 3: New Partnerships and Growth Projections - Vici Properties is actively seeking new partnerships, having established two significant relationships this year that will drive future growth [8] - The partnership with Cain International involves a $300 million mezzanine loan for the development of One Beverly Hills, a luxury mixed-use project [9] - A collaboration with Red Rock Resorts includes up to $510 million in funding for a tribal casino in California, marking Red Rock's first partnership with a REIT [10] Group 4: Financial Outlook - The company's success in forming new partnerships has led to an increase in its guidance for adjusted funds from operations (FFO), now projected to be between $2.33 and $2.36 per share, reflecting a 4.4% growth at the high end [11][12] - With a 5.5% yielding dividend, the total return could approach 10% if stock prices align with earnings growth, supporting continued dividend increases [12] Group 5: Overall Strategy Effectiveness - Vici Properties' strategy of partnering with leading operators continues to yield rising rental income and new investment opportunities, enhancing portfolio growth and shareholder value [13]

Core Insights - The current global trade environment is marked by rising tariffs and tensions, prompting investors to seek stability in defensive sectors that are less impacted by economic fluctuations [1][2] - Large-cap biotech companies with a strong domestic focus, such as Gilead Sciences, Amgen, and AbbVie, are gaining attention as potential defensive investments due to their reliance on the U.S. market [2][3] Biotech Companies Overview - Gilead Sciences derives approximately 70.0% of its Q1 2025 product revenue from the U.S., Amgen generates about 74.7% of its Q4 2024 product sales domestically, and AbbVie obtains roughly 74.8% of its Q1 2025 net revenue from the United States [3][4] - The significant concentration of domestic sales provides a buffer against retaliatory tariffs and economic downturns, as demand for essential medicines tends to be inelastic [4][5] Financial Performance and Stability - Gilead Sciences has a market capitalization of around $132.66 billion, with a year-to-date stock gain of 15.3% and a low Beta of approximately 0.32, indicating defensive characteristics [11][13] - Amgen, valued at approximately $156.41 billion, reported a positive year-to-date performance of +11.6% and a Beta of 0.59, suggesting lower volatility [15][16] - AbbVie has a market capitalization of roughly $345.22 billion, achieving a 9.8% operational revenue increase in Q1 2025, with a forward P/E ratio of about 15.85 [18][19] Policy Environment - Recent U.S. government policy shifts are creating a supportive environment for domestic biotech companies, focusing on onshoring and reshoring manufacturing to enhance supply chain resilience [6][8] - Strategies include financial incentives, direct government investments, and prioritizing domestically produced medicines through 'Buy American' initiatives [7][8] Investment Appeal - The combination of strong cash flows, healthy dividends, and low Beta scores makes U.S.-focused biotech companies appealing during uncertain times [21][20] - Analysts have a Moderate Buy consensus on Gilead and AbbVie, while Amgen is rated as a Hold, reflecting confidence in their defensive qualities amidst market volatility [11][19][15]

Core Viewpoint - The concept of blue chip stocks varies among investors, indicating a subjective nature in defining high-quality investments [1] Group 1 - The article emphasizes the importance of dividend investing in quality blue-chip stocks, Business Development Companies (BDCs), and Real Estate Investment Trusts (REITs) [2] - It highlights a buy-and-hold investment strategy focused on quality over quantity, aiming to supplement retirement income through dividends within the next 5-7 years [2] - The goal is to assist lower and middle-class workers in building investment portfolios comprised of high-quality, dividend-paying companies [2] Group 2 - The analyst has disclosed a beneficial long position in shares of Starbucks (SBUX) and PepsiCo (PEP), indicating a personal investment interest in these companies [3] - The article expresses personal opinions and does not involve compensation from any mentioned companies, ensuring an independent perspective [3] - Seeking Alpha clarifies that past performance does not guarantee future results and that the views expressed may not represent the platform as a whole [4]

Waste Management TodayWMWaste Management$233.60 +0.24 (+0.10%) 52-Week Range$196.59▼$239.32Dividend Yield1.41%P/E Ratio34.35Price Target$243.29Add to WatchlistInvestors got a split decision when Waste Management Inc. NYSE: WM reported earnings after the market closed on April 28. Earnings per share (EPS) of $1.67 beat analysts’ forecasts by eight cents. However, revenue came in at $6.02 billion, which was 1.4% lower than the $6.14 billion that was expected. To add more context, even with the miss, the comp ...

Barrick Gold Corporation (GOLD) is slated to come up with first-quarter 2025 results before the opening bell on May 7. The company’s performance is expected to reflect higher gold prices amid cost headwinds.The Zacks Consensus Estimate for first-quarter earnings has been revised 26.1% upward in the past 60 days. The consensus estimate for earnings is pegged at 29 cents per share, suggesting a 52.6% year-over-year rise. Image Source: Zacks Investment ResearchGOLD beat the Zacks Consensus Estimate for earning ...

Deployed $56 Million to Repurchase Shares in Q1 2025NEW YORK, May 2, 2025 /PRNewswire/ -- Criteo S.A. (NASDAQ: CRTO) ("Criteo" or the "Company"), the commerce media company, today announced financial results for the first quarter ended March 31, 2025.First Quarter 2025 Financial Highlights:The following table summarizes our consolidated financial results for the three months ended March 31, 2025: Three Months Ended March 31, 2025 2024 YoY Change (in millions, except EPS data) GAAP Resu ...

Click here for a two-week free trial , so we can help you achieve better long-term total returns and your financial dreams.My family and I are going on a two-week wedding vacation starting next week, so this article has to provide actionable investment ideas for whatever is likely to happen in the short term.He is a founding author of the investing group The Dividend Kings which focuses on helping investors safeguard and grow their money in all market conditions through the highest-quality dividend investme ...

ENGLEWOOD, Colo., May 2, 2025 /PRNewswire/ -- EchoStar Corporation (NASDAQ: SATS) will host a conference call to discuss its first quarter financial results on Friday, May 9, 2025, at 11 a.m. Eastern Time (ET). The conference call will be broadcast live in listen-only mode on EchoStar's Investor Relations website.To attend the call, please use the information below for dial-in access. When prompted on dial-in, please utilize the conference ID or ask for the "EchoStar Corporation Q1 2025 Earnings Conference ...

Marvel Biosciences Announces Closing of Second Tranche of Private PlacementMay 02, 2025 7:00 AM EDT | Source: Marvel Biosciences Corp.Calgary, Alberta--(Newsfile Corp. - May 2, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to announce that, further to its press release of March 28, 2025 and subject to approval of the TSX Venture Exchange (the "TSXV"), it has closed the second tranche ...